Status:
RECRUITING
Early DHA/ARA Supplementation in Growth-restricted Very Preterm Infants: A Randomized Clinical Trial
Lead Sponsor:
University of Alabama at Birmingham
Collaborating Sponsors:
Mead Johnson Nutrition
Conditions:
Infant Malnutrition
Light-For-Dates With Signs of Fetal Malnutrition
Eligibility:
All Genders
24-72 years
Phase:
NA
Brief Summary
Growth-restricted very preterm infants (VPT) are born without adequate fat mass (FM) deposits and low docosahexaenoic acid (DHA) concentrations. They often experience further declines in DHA concentra...
Eligibility Criteria
Inclusion
- Gestational ages between 22 0/7 - 32 6/7 weeks gestation
- \< 25th centile birthweight
Exclusion
- Major congenital/chromosomal anomalies
- Terminal illness in which decisions to withhold or limit support have been made
Key Trial Info
Start Date :
May 20 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2026
Estimated Enrollment :
152 Patients enrolled
Trial Details
Trial ID
NCT06207071
Start Date
May 20 2024
End Date
December 1 2026
Last Update
May 30 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Alabama at Birmingham
Birmingham, Alabama, United States, 35233